Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587444 · ClinicalTrials.gov registry record · Phase 3
Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass
A Phase 3 study of Postoperative Hemorrhage, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT00587444 is a Phase 3 study of Postoperative Hemorrhage that has completed, run by Mayo Clinic. The registered enrollment target is 270 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00587444, a Phase 3 study of Postoperative Hemorrhage, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
Study has been completed and is in the data analysis and manuscript writing phase of the project.
Conditions Studied
Interventions
- DRUG Heparin
- DRUG HH or high heparin
- DRUG heparin concentration HC
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2001-06 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587444
The ClinicalTrials.gov registry entry for NCT00587444 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Hemorrhage appearing as the primary indexed condition, and to 3 interventions - of which Heparin is the first listed.
NCT00587444 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00587444 about?
NCT00587444 is a clinical study titled "Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass". Study has been completed and is in the data analysis and manuscript writing phase of the project.
What is the current status of trial NCT00587444?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 270 participants. The study started on 2001-06. Estimated completion is 2007-10.
What conditions does trial NCT00587444 study?
This clinical trial studies the following conditions: Postoperative Hemorrhage.
What interventions are being tested in trial NCT00587444?
The interventions under investigation include: Heparin (DRUG), HH or high heparin (DRUG), heparin concentration HC (DRUG).
Who is sponsoring clinical trial NCT00587444?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00587444 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.